[
    [
        {
            "time": "",
            "original_text": "泰格医药: Q1业绩超预期, 内生高增长",
            "features": {
                "keywords": [
                    "泰格医药",
                    "Q1",
                    "业绩",
                    "超预期",
                    "内生",
                    "高增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药: Q1业绩超预期, 内生高增长",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "泰格医药(300347)：国内创新药上市进口价值持续挖掘",
            "features": {
                "keywords": [
                    "泰格医药",
                    "300347",
                    "国内",
                    "创新药",
                    "上市",
                    "进口价值",
                    "持续挖掘"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药(300347)：国内创新药上市进口价值持续挖掘",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "【泰格医药】Q1预告点评：19Q1业绩超预期，股权激励高要求彰显信心",
            "features": {
                "keywords": [
                    "泰格医药",
                    "Q1",
                    "预告",
                    "点评",
                    "19Q1",
                    "业绩",
                    "超预期",
                    "股权激励",
                    "高要求",
                    "彰显信心"
                ],
                "sentiment_score": 0.92,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【泰格医药】Q1预告点评：19Q1业绩超预期，股权激励高要求彰显信心",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "泰格医药: 主营业务维持高速增长, 关注国际化进程",
            "features": {
                "keywords": [
                    "泰格医药",
                    "主营业务",
                    "维持",
                    "高速增长",
                    "关注",
                    "国际化",
                    "进程"
                ],
                "sentiment_score": 0.88,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药: 主营业务维持高速增长, 关注国际化进程",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]